Finished
TSolution One® Total Knee Arthroplasty
NCT03017261 · Think Surgical Inc. · Updated 4 June 2020
- What is being tested
- TSolution One®
- For
- Osteoarthritis, Knee
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 21 years and older. About 115 people. The full rules are on the registry page.
- Where
- United States (6 sites)
- When
- Starts or started 18 Feb 2017, ends 26 June 2019. Registered 11 Jan 2017.
- Results
- Posted on the registry on 22 May 2020.
In the researchers' words
The goal of this prospective, non-randomized, multicenter clinical trial is to determine whether robotic-assisted total knee arthroplasty performed with TSolution One® System is safe and effective for use as an alternative to the conventional manual techniques. Clinical and radiographic outcomes for robotic-assisted total knee arthroplasty performed with the TSolution One® System will be collected preoperatively, intraoperatively, and postoperatively up to a follow-up period of no less than 6 months and no more than 12 months. These outcomes will be compared to the ones reported in the literature for conventional manual techniques.
Sites
- Hackensack University Medical CenterHackensack, New Jersey, United States
- NYU Langone Medical CenterNew York, New York, United States
- St. Francis Hospital, The Heart Center®Roslyn, New York, United States
- North Carolina Specialty HospitalDurham, North Carolina, United States
- St. Vincent Charity Medical CenterCleveland, Ohio, United States
- Houston Methodist West HospitalHouston, Texas, United States